Cutera (CUTR) Q2 2024 earnings summary

Executive summary

• Q2 2024 revenue was $34.4 million, down 44% year-over-year, driven by lower system sales, macroeconomic pressures, and the end of a skincare distribution agreement.

• Gross margin fell to 22.2% (GAAP) from 42.2% a year ago, impacted by product mix, lower manufacturing activity, and increased inventory reserves.

• International AviClear launch exceeded expectations, with strong utilization and positive customer feedback, while North America underwent sales force restructuring and leadership changes.

• Management implemented significant cost reductions, including workforce and expense cuts, and completed restructuring with an additional $10 million in annualized savings identified for 2025.

• Management raised substantial doubt about the ability to continue as a going concern due to recurring losses and declining cash balances.

Financial highlights

• Q2 2024 revenue: $34.4 million, down from $61.8 million in Q2 2023; H1 2024 revenue: $73.2 million, down 37% year-over-year.

• Gross margin: 22.2% (GAAP), 28.0% (non-GAAP), both down sharply from prior year; normalized margin excluding inventory reserves would have been 35%.

• Net loss: $24.7 million in Q2 2024, or $(1.23) per share; H1 2024 net loss: $47.5 million.

• Non-GAAP operating expenses were $30.9 million, down from $42.1 million year-over-year, reflecting restructuring savings.

• Ended Q2 with $84.3 million in cash, down from $105.4 million at March 31, 2024, and $143.6 million at year-end 2023.

Outlook and guidance

• Full-year 2024 revenue guidance revised to $140–$145 million, down from $160–$170 million.

• Year-end cash balance expected to be ~$40 million, revised from previous $55–$60 million.

• Management expects continued operating losses and negative cash flow, with ongoing uncertainty about the ability to continue as a going concern.

• Anticipates over $50 million year-over-year improvement in cash burn from 2024 to 2025, mainly from inventory reduction and expense cuts.

• Future operations depend on revenue growth from the revised AviClear direct sales model, cost savings, and potential additional financing.